Tim Kottke

1.7k total citations
39 papers, 1.3k citations indexed

About

Tim Kottke is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Tim Kottke has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 20 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Tim Kottke's work include Virus-based gene therapy research (13 papers), Mast cells and histamine (13 papers) and Immunotherapy and Immune Responses (11 papers). Tim Kottke is often cited by papers focused on Virus-based gene therapy research (13 papers), Mast cells and histamine (13 papers) and Immunotherapy and Immune Responses (11 papers). Tim Kottke collaborates with scholars based in United States, Germany and United Kingdom. Tim Kottke's co-authors include Holger Stark, Kerstin Sander, Richard G. Vile, Lilia Weizel, Alan Melcher, Jill Thompson, Kevin J. Harrington, Roland Seifert, Erich Schneider and Rosa María Díaz and has published in prestigious journals such as Nature Medicine, Nature Communications and Cancer Research.

In The Last Decade

Tim Kottke

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Kottke United States 20 662 606 417 386 142 39 1.3k
Elizabeth M. Hadac United States 29 1.8k 2.7× 152 0.3× 503 1.2× 487 1.3× 54 0.4× 57 2.5k
Jia Xie United States 21 651 1.0× 227 0.4× 78 0.2× 228 0.6× 76 0.5× 37 1.2k
Liangwu Sun United States 19 747 1.1× 207 0.3× 312 0.7× 66 0.2× 104 0.7× 21 1.1k
Marianne Braun Germany 9 611 0.9× 296 0.5× 82 0.2× 154 0.4× 18 0.1× 11 1.2k
Brigitte Boldyreff Germany 25 1.8k 2.7× 94 0.2× 260 0.6× 355 0.9× 37 0.3× 51 2.2k
Ronald Adamik United States 25 1.4k 2.0× 469 0.8× 141 0.3× 286 0.7× 23 0.2× 50 1.9k
Wade Edris United States 17 1.0k 1.6× 269 0.4× 114 0.3× 236 0.6× 28 0.2× 31 1.5k
Antonino Colanzi Italy 27 1.8k 2.7× 155 0.3× 194 0.5× 162 0.4× 34 0.2× 52 2.6k
Alejandro López‐Requena Cuba 19 492 0.7× 360 0.6× 43 0.1× 170 0.4× 38 0.3× 43 1.1k
Jonathan D. Silk United Kingdom 20 342 0.5× 1.6k 2.7× 58 0.1× 467 1.2× 49 0.3× 28 2.0k

Countries citing papers authored by Tim Kottke

Since Specialization
Citations

This map shows the geographic impact of Tim Kottke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Kottke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Kottke more than expected).

Fields of papers citing papers by Tim Kottke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Kottke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Kottke. The network helps show where Tim Kottke may publish in the future.

Co-authorship network of co-authors of Tim Kottke

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Kottke. A scholar is included among the top collaborators of Tim Kottke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Kottke. Tim Kottke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huff, Amanda L., Laura Evgin, Jill Thompson, et al.. (2020). Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses. Molecular Therapy. 28(12). 2540–2552. 5 indexed citations
2.
Evgin, Laura, Amanda L. Huff, Phonphimon Wongthida, et al.. (2020). Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nature Communications. 11(1). 3187–3187. 92 indexed citations
3.
Shim, Kevin G., Shane Zaidi, Jill Thompson, et al.. (2017). Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy. Molecular Therapy. 25(4). 962–975. 19 indexed citations
4.
Sadek, Bassem, et al.. (2017). Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands. Frontiers in Chemistry. 5. 64–64. 12 indexed citations
5.
Kottke, Tim, Kevin G. Shim, Vanesa Alonso-Camino, et al.. (2016). Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy — Oncolytics. 3. 16030–16030. 3 indexed citations
6.
Ilett, Elizabeth J., Tim Kottke, Jill Thompson, et al.. (2016). Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. Gene Therapy. 24(1). 21–30. 59 indexed citations
7.
Łażewska, Dorota, Małgorzata Więcek, Katarzyna H. Kaminska, et al.. (2014). Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands. European Journal of Medicinal Chemistry. 83. 534–546. 47 indexed citations
8.
Zaidi, Shane, Kevin G. Shim, Elizabeth J. Ilett, et al.. (2014). Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents. Molecular Therapy. 23(5). 845–856. 11 indexed citations
9.
Kottke, Tim, Kerstin Sander, Lilia Weizel, et al.. (2011). Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands. European Journal of Pharmacology. 654(3). 200–208. 58 indexed citations
10.
Walter, Miriam, Tim Kottke, & Holger Stark. (2011). The histamine H4 receptor: Targeting inflammatory disorders. European Journal of Pharmacology. 668(1-2). 1–5. 34 indexed citations
11.
Więcek, Małgorzata, Tim Kottke, Xavier Ligneau, et al.. (2011). N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands. Bioorganic & Medicinal Chemistry. 19(9). 2850–2858. 20 indexed citations
12.
Sander, Kerstin, Tim Kottke, Miriam Walter, et al.. (2010). First Metal-Containing Histamine H 3 Receptor Ligands. Organic Letters. 12(11). 2578–2581. 16 indexed citations
13.
Karcz, Tadeusz, Jadwiga Handzlik, Dorota Łażewska, et al.. (2010). Search for histamine H4 receptor ligands in the group of 4-methylpiperazino amide derivatives. Inflammation Research. 59(S2). 243–245. 1 indexed citations
14.
Kuder, Kamil, Tim Kottke, Holger Stark, et al.. (2009). Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties. Inflammation Research. 59(S2). 247–248. 10 indexed citations
15.
Sander, Kerstin, Tim Kottke, Ewgenij Proschak, et al.. (2009). Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands. Inflammation Research. 59(S2). 249–251. 7 indexed citations
16.
Łażewska, Dorota, Małgorzata Więcek, Xavier Ligneau, et al.. (2009). Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorganic & Medicinal Chemistry Letters. 19(23). 6682–6685. 18 indexed citations
17.
Sander, Kerstin, Tim Kottke, Yusuf Tanrıkulu, et al.. (2009). 2,4-Diaminopyrimidines as histamine H4 receptor ligands—Scaffold optimization and pharmacological characterization. Bioorganic & Medicinal Chemistry. 17(20). 7186–7196. 63 indexed citations
18.
Larmonier, Nicolas, Dominique Cathelin, Claire B. Larmonier, et al.. (2007). The inhibition of TNF-α anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Experimental Cell Research. 313(11). 2345–2355. 32 indexed citations
19.
Qiao, Jing, Leonor Sánchez‐Pérez, Tim Kottke, et al.. (2006). VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Gene Therapy. 13(20). 1457–1470. 18 indexed citations
20.
Phan, Vy, Fiona Errington‐Mais, Tim Kottke, et al.. (2003). A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nature Medicine. 9(9). 1215–1219. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth M. Hadac Breakdown of academic impact, for papers by Jia Xie Breakdown of academic impact, for papers by Liangwu Sun Breakdown of academic impact, for papers by Marianne Braun Breakdown of academic impact, for papers by Brigitte Boldyreff Breakdown of academic impact, for papers by Ronald Adamik Breakdown of academic impact, for papers by Wade Edris Breakdown of academic impact, for papers by Antonino Colanzi Breakdown of academic impact, for papers by Alejandro López‐Requena Breakdown of academic impact, for papers by Jonathan D. Silk
Rankless by CCL
2026